Cover Image

Can anti-TNFα Antibodies Affect SARS-CoV-2 Disease Outcomes?

Saved in:

Bibliographic Details
Main Author:	Mohammad Reza Khazdair (Author)
Format:	Book
Published:	Tabriz University of Medical Sciences, 2022-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
by: Lorenza Romani, et al.
Published: (2022)

High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad
by: Andrillene Laure Deutou Wondeu, et al.
Published: (2022)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
by: Marco Tuccori, et al.
Published: (2020)

Does SARS-CoV-2 in Pregnancy Affect Newborn Outcomes?
by: Marjana Jerković Raguž, et al.
Published: (2022)

Anti-SARS-CoV-2 antibodies important in diagnostics of acute hepatitis in children
by: Małgorzata Pawłowska, et al.
Published: (2023)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

The analysis of characteristics of anti-SARS-CoV-2 antibodies in clinically COVID-19 patients
by: Wenzheng Guo, et al.
Published: (2020)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
by: Shinta Oktya Wardhani, et al.
Published: (2021)

Waning antibodies to SARS-CoV-2 - Don't panic
by: Benjamin Meyer
Published: (2021)

Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020)

Anti-SARS-CoV-2-specific antibodies in human breast milk following SARS-CoV-2 infection during pregnancy: a prospective cohort study
by: Irene Fernández-Buhigas, et al.
Published: (2024)

Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study
by: Marcela Mercado-Reyes, et al.
Published: (2022)

Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
by: Yao J, et al.
Published: (2021)

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
by: Wen Jiang, et al.
Published: (2021)

Can Robots Improve Testing Capacity for SARS-CoV-2?
by: Cresswell, Kathrin, et al.
Published: (2020)

Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers
by: Amit Bansal, et al.
Published: (2023)

SARS-CoV-2 Antibody Response to Vaccination in Peritoneal Dialysis Patients
by: Beatriz Donato, et al.
Published: (2023)

Potential Anti-SARS-CoV-2 Molecular Strategies
Published: (2023)

Cord Blood SARS-CoV-2 IgG Antibodies and Their Association With Maternal Immunity and Neonatal Outcomes
by: Addy Cecilia Helguera-Repetto, et al.
Published: (2022)

Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response
by: Marc-Kendy Paul, et al.
Published: (2024)

SARS-CoV-2 anti-N antibodies among healthcare personnel without previous known COVID-19
by: Sajal Tiwary, et al.
Published: (2024)

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
by: Marie Kroemer, et al.
Published: (2022)

Preparation, Purification and Performance Evaluation of Polyclonal Antibody Against SARS-CoV-2 Produced in Rat
by: Fatemeh Yaghoobizadeh, et al.
Published: (2023)

Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman
by: Khalid Al-Naamani, et al.
Published: (2021)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
by: Xingsu Gao, et al.
Published: (2022)

Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
by: Khan Sharun, et al.
Published: (2021)

Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain
by: Ping-Han Huang, et al.
Published: (2021)

Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein
by: Curtis D. Hodge, et al.
Published: (2021)

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
by: Eugenia Quiros-Roldan, et al.
Published: (2021)

Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease
by: Luca Bosa, et al.
Published: (2022)

Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva
by: Thomas J. Ketas, et al.
Published: (2021)

Neutralizing Antibody Response by Inactivated SARS-CoV-2 Vaccine on Healthcare Workers
by: Nataniel Tandirogang, et al.
Published: (2023)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
by: Wu Zhong, et al.
Published: (2022)

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
by: Andrew Dippel, et al.
Published: (2023)

Possible correlation of electrochemiluminescence based numerical cut off index value with concentration of anti-SARS-CoV-2 antibody: Is it worth reporting?
by: Shabnum Khawaja, et al.
Published: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study
by: Carlos Álvarez-Antonio, MD, et al.
Published: (2021)